Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01249248 · ClinicalTrials.gov registry record
PD2i Analysis of Heart Rate Variability in Competitive Sports
A clinical trial, sponsored by University of Mississippi Medical Center.
- Completed
- Registry status
- 90
- Enrollment target
NCT01249248: Completed study, sponsored by University of Mississippi Medical Center.
NCT01249248 is a clinical trial that has completed, run by University of Mississippi Medical Center. The registered enrollment target is 90 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01249248 has completed, sponsored by University of Mississippi Medical Center.
- COMPLETED
- Registry status
- 90 participants
- Enrollment target
Study Summary
This is a double blind observational analysis of changes in heart rate variability using PD2i analyser in competitive athletes during strenuous exercise and competition.
Primary Outcome
PD2i analysis of HRV measured before and after strenuous exercise in each sport. The change from baseline will be correlated to return to resting heart rate.
Interventions
- DEVICE PD2i Analyzer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2010-10 |
| Est. Completion | 2011-07 |
What the finished NCT01249248 record still lists
NCT01249248 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 90 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which PD2i Analyzer is the first listed.
NCT01249248 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01249248 about?
NCT01249248 is a clinical study titled "PD2i Analysis of Heart Rate Variability in Competitive Sports". This is a double blind observational analysis of changes in heart rate variability using PD2i analyser in competitive athletes during strenuous exercise and competition.
What is the current status of trial NCT01249248?
This trial is currently completed. The enrollment target is 90 participants. The study started on 2010-10. Estimated completion is 2011-07.
What interventions are being tested in trial NCT01249248?
The interventions under investigation include: PD2i Analyzer (DEVICE).
Who is sponsoring clinical trial NCT01249248?
This trial is sponsored by University of Mississippi Medical Center, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02521311 · 90 participants · Phase 2
Assessment of Clemastine Fumarate as a Remyelinating Agent in Acute Optic Neuritis (ReCOVER)
- NCT02939573 · 90 participants · Phase 2
A Randomized Multicenter Study for Isolated Skin Vasculitis
- NCT03128879 · 90 participants · Phase 2
Venetoclax With Ibrutinib or Acalabrutinib in Pts. With High-risk CLL
- NCT03184038 · 90 participants · NA
Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia